This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Alfie, M. E. Articles by Carretero, O. A. Search for Related Content PubMed PubMed Citation Articles by Alfie, M. E. Articles by Carretero, O. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Related Collections Animal models of human disease Hypertension - basic studies Receptor pharmacology

(Hypertension. 1999;33:1436-1440.)
© 1999 American Heart Association, Inc.

Scientific Contribution

An Enhanced Effect of Arginine Vasopressin in Bradykinin B₂ Receptor Null Mutant Mice

Marcos E. Alfie; Shainda Alim; Dharmesh Mehta; Edward G. Shesely; Oscar A. Carretero

From the Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, Mich 48202.

Correspondence to Oscar A. Carretero, MD, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202. E-mail ocarret1{at}hfhs.org

Abstract—Under water restriction, arginine vasopressin (AVP) is released and promotes water reabsorption in the distal nephron, mainly through AVP V₂-receptors. It has been proposed that renal kinins counteract the hydro-osmotic effect of AVP. We hypothesized that kinins acting through B₂ receptors antagonize the urinary concentrating effect of AVP. To test this, bradykinin B₂ receptor knockout mice (B₂-KO) and 129/SvEv mice (controls) were placed in metabolic cages and urine collected for 24 hours (water ad libitum). After that, urine was again collected from the same mice during 24 hours of water restriction. Urinary volume (UV), urinary osmolarity (UOsm), and urinary Na⁺ (U_NaV) and K⁺ (U_KV) excretion were determined. On water restriction, UV in controls decreased by 25%, whereas in B₂-KO mice there was almost a 60% drop in urinary output (P=0.001 versus controls). In the controls, water restriction increased UOsm by 347 mOsm/kg H₂O, 14% above baseline (NS), whereas in knockout mice the increase was 3 times that seen in the controls: >1000 mOsm/kg H₂O (P=0.001 versus controls). Compared with normohydration, U_NaV and U_KV in the water-restricted state increased more in controls than in B₂-KO mice. This difference in electrolyte excretion could be explained by greater dehydration in the controls (dehydration natriuresis). In a second protocol, we tried to mimic the effect of endogenous AVP by exogenous administration of an AVP V₂-receptor agonist, desmopressin (DDAVP). To suppress endogenous AVP levels before DDAVP administration, mice were volume-overloaded with dextrose and alcohol. UOsm was 685±125 and 561±58 mOsm/kg H₂O in water-loaded controls and B₂-KO mice, respectively. After DDAVP was injected subcutaneously at a dose of 1 µg/kg, UOsm increased to 1175±86 mOsm/kg H₂O (+490 mOsm) in the controls and 2347±518 mOsm/kg H₂O (+1786 mOsm) in B₂-KO mice (P<0.05 versus controls). We concluded that water restriction or exogenous administration of an AVP V₂-receptor agonist has a greater urinary concentrating effect in B₂-KO mice than in controls, suggesting that endogenous kinins acting through B₂ receptors oppose the antidiuretic effect of AVP in vivo.

Key Words: mice, knockout • bradykinin • argipressin • desmopressin • urine

This article has been cited by other articles:

				R. A. Fenton and M. A. Knepper Mouse Models and the Urinary Concentrating Mechanism in the New Millennium Physiol Rev, October 1, 2007; 87(4): 1083 - 1112. [Abstract] [Full Text] [PDF]

				C. J. Saunders, L. de Milander, T. Hew-Butler, S. L. Xenophontos, M. A. Cariolou, L. C. Anastassiades, T. D. Noakes, and M. Collins Dipsogenic genes associated with weight changes during Ironman Triathlons Hum. Mol. Genet., October 15, 2006; 15(20): 2980 - 2987. [Abstract] [Full Text] [PDF]

				L. J. Mullins, M. A. Bailey, and J. J. Mullins Hypertension, Kidney, and Transgenics: A Fresh Perspective Physiol Rev, April 1, 2006; 86(2): 709 - 746. [Abstract] [Full Text] [PDF]

				G. Tamma, M. Carmosino, M. Svelto, and G. Valenti Bradykinin Signaling Counteracts cAMP-Elicited Aquaporin 2 Translocation in Renal Cells J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2881 - 2889. [Abstract] [Full Text] [PDF]

				L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF]

				C. P. Thomas, R. W. Loftus, and K. Z. Liu AVP-induced VIT32 gene expression in collecting duct cells occurs via trans-activation of a CRE in the 5'-flanking region of the VIT32 gene Am J Physiol Renal Physiol, September 1, 2004; 287(3): F460 - F468. [Abstract] [Full Text] [PDF]

				M. A. Cadnapaphornchai, B. Rogachev, S. N. Summer, Y.-C. Chen, L. Gera, J. M. Stewart, and R. W. Schrier Evidence for bradykinin as a stimulator of thirst Am J Physiol Renal Physiol, May 1, 2004; 286(5): F875 - F880. [Abstract] [Full Text] [PDF]

				P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice PNAS, February 15, 2001; (2001) 51619598. [Abstract] [Full Text]

				P. Meneton, M. Bloch-Faure, A. A. Hagege, H. Ruetten, W. Huang, S. Bergaya, D. Ceiler, D. Gehring, I. Martins, G. Salmon, et al. Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice PNAS, February 27, 2001; 98(5): 2634 - 2639. [Abstract] [Full Text] [PDF]